Endometrial Cancer

>

Latest News

Powell Reviews Updated IO/TKI Data and AE Management in Endometrial Cancer
Powell Reviews Updated IO/TKI Data and AE Management in Endometrial Cancer

April 18th 2024

During a Case-Based Roundtable® event, Matthew A. Powell, MD, discussed the case of a patient with advanced endometrial cancer treated with lenvatinib plus pembrolizumab who experienced grade 2 treatment-related hypertension.

Roundtable Roundup: Surveying Oncologists on Endometrial Cancer Treatment
Roundtable Roundup: Surveying Oncologists on Endometrial Cancer Treatment

March 27th 2024

First-Line Durvalumab Betters Survival in Advanced Endometrial Cancer
First-Line Durvalumab Betters Survival in Advanced Endometrial Cancer

March 19th 2024

Ghamande Reviews Latest Chemoimmunotherapy Trials for Endometrial Cancer
Ghamande Reviews Latest Chemoimmunotherapy Trials for Endometrial Cancer

March 19th 2024

Lenvatinib/Pembrolizumab Improves Survival in Advanced/Recurrent Endometrial Cancer
Lenvatinib/Pembrolizumab Improves Survival in Advanced/Recurrent Endometrial Cancer

March 19th 2024

Video Series
Video Interviews
Podcasts

More News